European Journal of Molecular & Clinical Medicine

Abstract

Telogen effluvium (TE) is a diffuse, non-scarring hair loss
characterized by shortening of the anagen phase and precipitation of the telogen
phase that leads to consequent decreasing of the total hair volume. Identifying and
correcting the underlying cause is the most important component in management.
Minoxidil is mainly used for the treatment of male and female androgenetic
alopecia but it has a place in TE management. The goal of mesotherapy in
management of some types of hair disorder is to restore and increase local
microcirculation, provide nutritional input, slow down the programmed process of
follicular involution.